<SEC-DOCUMENT>0001193125-18-154426.txt : 20180507
<SEC-HEADER>0001193125-18-154426.hdr.sgml : 20180507
<ACCEPTANCE-DATETIME>20180507160807
ACCESSION NUMBER:		0001193125-18-154426
CONFORMED SUBMISSION TYPE:	S-3ASR
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20180507
DATE AS OF CHANGE:		20180507
EFFECTIVENESS DATE:		20180507

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WEIGHT WATCHERS INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000105319
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PERSONAL SERVICES [7200]
		IRS NUMBER:				116040273
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1230

	FILING VALUES:
		FORM TYPE:		S-3ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-224714
		FILM NUMBER:		18811289

	BUSINESS ADDRESS:	
		STREET 1:		675 AVENUE OF THE AMERICAS
		STREET 2:		6TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
		BUSINESS PHONE:		2125892700

	MAIL ADDRESS:	
		STREET 1:		675 AVENUE OF THE AMERICAS
		STREET 2:		6TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3ASR
<SEQUENCE>1
<FILENAME>d582596ds3asr.htm
<DESCRIPTION>S-3ASR
<TEXT>
<HTML><HEAD>
<TITLE>S-3ASR</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on May 7, 2018. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="right"><B>Registration No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">S-3</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>WEIGHT WATCHERS INTERNATIONAL, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in Its Charter) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ALIGN="center"><B>Virginia</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">11-6040273</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Incorporation or Organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>675 Avenue of the Americas, 6th Floor </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>New York, New York 10010 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(212) <FONT STYLE="white-space:nowrap">589-2700</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant&#146;s Principal Executive Offices) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Michael F. Colosi, Esq. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Weight Watchers International, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>675 Avenue of the Americas, 6th Floor </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>New York, New York 10010 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(212) <FONT STYLE="white-space:nowrap">589-2700</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B><I>With copies to: </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Kenneth B. Wallach, Esq. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Xiaohui (Hui) Lin, Esq. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Simpson Thacher &amp; Bartlett LLP </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>425 Lexington Avenue </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>New
York, New York 10019 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(212) <FONT STYLE="white-space:nowrap">455-2000</FONT> </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Approximate date of commencement of proposed sale to the public: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>From time to time after the effective date of this Registration Statement. </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the
following box:&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis
pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box:&nbsp;&nbsp;&#9746; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">If
this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following
box.&nbsp;&nbsp;&#9746; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D.
filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
<FONT STYLE="white-space:nowrap">non-accelerated</FONT> filer, a smaller reporting company, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting
company&#148; and &#147;emerging growth company&#148; in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated&nbsp;filer</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;&nbsp;&nbsp;(Do not check if a smaller reporting company)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:3%; font-size:8pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of Securities Act.&nbsp;&nbsp;&#9744; </P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF REGISTRATION FEE </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of Each Class&nbsp;of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Securities to be Registered</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Registered</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Offering
Price</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Per Share</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Maximum<BR>Aggregate</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Offering Price</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount of<BR>Registration Fee</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Common stock, no par value</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">(1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">(1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">(1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">(1)(2)</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Omitted pursuant to General Instruction II.E of Form <FONT STYLE="white-space:nowrap">S-3.</FONT> An indeterminate aggregate amount of common stock is being registered as may from time to time be offered at
indeterminate prices. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, the registrant is deferring payment of all of the registration fee. In connection with the securities offered hereby, the registrant will pay <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;pay-as-you-go</FONT></FONT></FONT> registration fees&#148; in accordance with Rule 456(b). </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g582596g72v68.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Weight Watchers International, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling shareholder may
offer and sell from time to time shares of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selling shareholder will determine when and how to sell shares of our common stock
offered hereby, which may be sold on a continuous or delayed basis directly, to or through agents, dealers, brokers or underwriters as designated from time to time, or through a combination of these methods. The selling shareholder reserves the sole
right to accept, and they and any agents, dealers, brokers and underwriters reserve the right to reject, in whole or in part, any proposed purchase of shares of our common stock. If any agents, dealers, brokers or underwriters are involved in the
sale of any shares of our common stock, the applicable prospectus supplement will set forth any applicable commissions or discounts payable to them. We will not receive any proceeds from the sale of the shares of our common stock by the selling
shareholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each time that the selling shareholder sells shares of our common stock using this prospectus, we will provide a prospectus supplement and
attach it to this prospectus and may also provide you with a free writing prospectus. The prospectus supplement and any free writing prospectus will contain more specific information about the offering and the shares of our common stock being
offered and the prices at which the shares of our common stock are sold. The prospectus supplement or free writing prospectus may also add, update, change or clarify information contained in or incorporated by reference into this prospectus. This
prospectus may not be used to sell shares of our common stock unless accompanied by a prospectus supplement describing the method and terms of the offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the New York Stock Exchange (&#147;NYSE&#148;) under the symbol &#147;WTW.&#148; </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>Investing in our common stock involves a high degree of risk. See &#147;<A HREF="#rom582596_5">Risk Factors</A>&#148; beginning on page 2 of this
prospectus, in any applicable prospectus supplement and in the documents incorporated or deemed incorporated by reference into this prospectus before investing in our common stock. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this
prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The date of this prospectus is
May 7, 2018. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>In making your investment decision, you should rely only on the information contained in
or incorporated by reference into this prospectus or a prospectus supplement. Neither we nor the selling shareholder have authorized anyone to provide you with any other information or represent anything about us or this offering that is not
contained in or incorporated by reference into this prospectus or a prospectus supplement. If you receive any such other information or representation, it should not be relied upon as having been authorized by us or the selling shareholder. We take
no responsibility for, and can provide no assurance as to the accuracy of, any other information that others may give you. We and the selling shareholder are not making an offer to sell, or soliciting an offer to buy, any of these shares of common
stock in any jurisdiction where, or to any person to whom, an offer, solicitation or sale is not permitted. Shares of common stock are being offered for sale only in places where offers and sales are permitted.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>You should not assume that the information contained in or incorporated by reference into this prospectus or any applicable prospectus
supplement or any free writing prospectus prepared by us or on our behalf, is accurate as of any date other than the date on the front cover of the relevant document. Neither the delivery of this prospectus or any applicable prospectus supplement
nor any sale made using this prospectus or any applicable prospectus supplement shall under any circumstances imply that the information herein is correct as of any date subsequent to the date on the front cover of the relevant document. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom582596_1">About This Prospectus</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom582596_2">Trademarks, Service Marks and Copyrights</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom582596_3">Cautionary Statement Regarding Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom582596_4">Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom582596_5">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom582596_6">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom582596_7">The Selling Shareholder</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom582596_8">Description of Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom582596_9">Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom582596_10">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom582596_11">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom582596_12">Where You Can Find Additional Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom582596_13">Incorporation of Certain Information by Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom582596_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> that we filed with the Securities and
Exchange Commission (the &#147;SEC&#148;) using a &#147;shelf&#148; registration process. Under this shelf registration process, the selling shareholder may, from time to time, offer and/or sell shares of our common stock in one or more offerings or
resales. This prospectus provides you with a general description of the shares of our common stock that the selling shareholder may offer. Each time the selling shareholder sells shares of our common stock using this prospectus, we will provide a
prospectus supplement and attach it to this prospectus and may also provide you with a free writing prospectus. The prospectus supplement and any free writing prospectus will contain more specific information about the offering and the shares of our
common stock being offered and the prices at which those shares of our common stock&nbsp;are sold. The prospectus supplement may also add, update, change or clarify information contained in or incorporated by reference into this prospectus. If there
is any inconsistency between the information in this prospectus and the information in the prospectus supplement, you should rely on the information in the prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS PROSPECTUS MAY NOT BE USED TO SELL ANY SHARES OF OUR COMMON STOCK UNLESS ACCOMPANIED BY A PROSPECTUS SUPPLEMENT. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rules of the SEC allow us to incorporate by reference information into this prospectus. This means that important information is contained
in other documents that are considered to be a part of this prospectus. Additionally, information that we file later with the SEC will automatically update and supersede this information. You should carefully read both this prospectus and the
applicable prospectus supplement together with the additional information that is incorporated or deemed incorporated by reference into this prospectus or the applicable prospectus supplement. See &#147;Incorporation of Certain Information by
Reference&#148; before making an investment in our common stock. This prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information.
All of the summaries are qualified in their entirety by the actual documents. Copies of the documents referred to herein have been filed or will be filed or incorporated by reference as exhibits to the registration statement of which this prospectus
is a part. The registration statement, including the exhibits and documents incorporated or deemed incorporated by reference into this prospectus, can be read on the SEC website or at the SEC offices mentioned under the heading &#147;Where You Can
Find Additional Information.&#148; </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom582596_2"></A>TRADEMARKS, SERVICE MARKS AND COPYRIGHTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We own or have rights to trademarks, service marks or trade names that we use in connection with the operation of our business, including
Weight Watchers<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, PointsPlus<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, ProPoints<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, SmartPoints<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, Points<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, WW Freestyle<SUP STYLE="font-size:85%; vertical-align:top">TM </SUP>and the WW logo. In addition, our names, logos and website
names and addresses are our service marks or trademarks. Other trademarks, service marks and trade names appearing in this prospectus are the property of their respective owners. We also own or have the rights to copyrights that protect the content
of our products. Solely for convenience, the trademarks, service marks, tradenames and copyrights referred to in this prospectus are listed without the <SUP STYLE="font-size:85%; vertical-align:top">&copy;</SUP>, <SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and &#153; symbols, but we will assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks and tradenames. We do
not intend our use or display of other parties&#146; trademarks, trade names or service marks to imply, and such use or display should not be construed to imply, a relationship with, or endorsement or sponsorship of us by, those other parties. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom582596_3"></A>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except for historical information contained herein, this prospectus (including any prospectus supplement and the information incorporated or
deemed to be incorporated by reference into this prospectus or such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
prospectus supplement) and any free writing prospectus that we may provide to you in connection with an offering of our common stock described in this prospectus include &#147;forward-looking
statements,&#148; within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), including, in particular, the statements
about our plans, strategies and prospects under the headings &#147;Business&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations.&#148; We have generally used the words &#147;may,&#148;
&#147;will,&#148; &#147;could,&#148; &#147;expect,&#148; &#147;anticipate,&#148; &#147;believe,&#148; &#147;estimate,&#148; &#147;plan,&#148; &#147;intend,&#148; &#147;aim,&#148; &#147;target&#148; and similar expressions in this prospectus and the
documents incorporated by reference herein to identify forward-looking statements. We have based these forward-looking statements on our current views with respect to future events and financial performance. Actual results could differ materially
from those projected in these forward-looking statements. These forward-looking statements are subject to risks, uncertainties and assumptions, including, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">competition from other weight management and wellness industry participants or the development of more effective or more favorably perceived weight management methods; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to continue to develop new, innovative services and products and enhance our existing services and products or the failure of our services, products or brands to continue to appeal to the market, or our
ability to successfully expand into new channels of distribution or respond to consumer trends; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability to successfully implement new strategic initiatives; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the effectiveness of our advertising and marketing programs, including the strength of our social media presence; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the impact on our reputation of actions taken by our franchisees, licensees, suppliers and other partners; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the impact of our substantial amount of debt, and our debt service obligations and debt covenants; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the inability to generate sufficient cash to service our debt and satisfy our other liquidity requirements; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">uncertainties regarding the satisfactory operation of our technology or systems; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the impact of security breaches or privacy concerns; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the recognition of asset impairment charges; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the loss of key personnel, strategic partners or consultants or failure to effectively manage and motivate our workforce; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the inability to renew certain of our licenses, or the inability to do so on terms that are favorable to us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the expiration or early termination by us of leases; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">risks and uncertainties associated with our international operations, including regulatory, economic, political and social risks and foreign currency risks; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">uncertainties related to a downturn in general economic conditions or consumer confidence; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to successfully make acquisitions or enter into joint ventures, including our ability to successfully integrate, operate or realize the anticipated benefits of such businesses; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the seasonal nature of our business; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the impact of events that discourage or impede people from gathering with others or accessing resources; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to enforce our intellectual property rights both domestically and internationally, as well as the impact of our involvement in any claims related to intellectual property rights; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the outcomes of litigation or regulatory actions; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the impact of existing and future laws and regulations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our failure to maintain effective internal control over financial reporting; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the possibility that the interests of Artal Group S.A., together with its parents and its subsidiaries (&#147;Artal&#148;), who effectively controls us, will conflict with other holders of our common stock; and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should not put undue reliance on any forward-looking statements. You should understand that many important factors, including those
discussed in the &#147;Risk Factors&#148; section of our annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;30, 2017 (the &#147;2017 <FONT STYLE="white-space:nowrap">10-K&#148;)</FONT> and the
&#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; section of the 2017 <FONT STYLE="white-space:nowrap">10-K</FONT> and our quarterly report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for
the three months ended March&nbsp;31, 2018 could cause our results to differ materially from those expressed or suggested in any forward-looking statement. Except as required by law, we do not undertake any obligation to update or revise these
forward-looking statements to reflect new information or events or circumstances that occur after the date of this prospectus or to reflect the occurrence of unanticipated events or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom582596_4"></A>SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights certain significant aspects of our business. This is a summary of information contained elsewhere or incorporated
by reference into this prospectus or any prospectus supplement, is not complete, and does not contain all of the information that you should consider before making your investment decision. You should carefully read the entire prospectus, any
prospectus supplement, the documents incorporated herein or therein and any free writing prospectus prepared by us or on our behalf, before making an investment decision. In this prospectus, unless the context indicates otherwise, &#147;we,&#148;
&#147;us,&#148; &#147;our,&#148; &#147;Company,&#148; &#147;Weight Watchers,&#148; &#147;WWI&#148; and similar terms refer to Weight Watchers International, Inc. and all of its subsidiaries. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Our Company </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a
global wellness company and the world&#146;s leading commercial weight management program. We have helped millions of people around the world develop healthy habits and lose weight through a science-led, sensible, sustainable and personalized
approach that fits into their lives. We connect with our members in the way they want to be engaged, digitally and at in-person meetings. We have built a growing and loyal member community and a company with strong revenue growth, margins and cash
flow from operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Corporate Information </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive offices are located at 675 Avenue of the Americas, 6th Floor, New York, NY 10010. Our telephone number is (212) <FONT
STYLE="white-space:nowrap">589-2700.</FONT> Our website address is https://www.weightwatchersinternational.com. The information on our website does not constitute part of, and is not incorporated into, this prospectus, and you should rely only on
the information contained in or incorporated by reference into this prospectus or any applicable prospectus supplement when making a decision as to whether to invest in our common stock. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom582596_5"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An investment in shares of our common stock involves a significant degree of risk. Before you decide whether to purchase the shares of common
stock, you should carefully consider the risk factors contained in the 2017 <FONT STYLE="white-space:nowrap">10-K,</FONT> which is incorporated by reference into this prospectus, and under the caption &#147;Risk Factors&#148; or any similar caption
in the other documents and reports that we file with the SEC after the date of this prospectus that are incorporated or deemed to be incorporated by reference into this prospectus as well as any risks described in or incorporated by reference into
any applicable prospectus supplement or free writing prospectus that we provide you in connection with an offering of common stock pursuant to this prospectus. See &#147;Where You Can Find Additional Information&#148; and &#147;Incorporation of
Certain Information by Reference.&#148; These risks and uncertainties are not the only risks and uncertainties that we face. Additional risks and uncertainties not currently known to us or that we currently deem immaterial also may impair our
business, financial condition or results of operations and impact the price of our common stock. If any of these risks or uncertainties actually occur, our business, financial condition or results of operations and the price of our common stock
could suffer. These risks also include forward-looking statements and our actual results may differ substantially from those discussed in those forward-looking statements. See &#147;Cautionary Statement Regarding Forward-Looking Statements.&#148;
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom582596_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not receive any proceeds from the sale of shares of our common stock by the selling shareholder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom582596_7"></A>THE SELLING SHAREHOLDER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One or more affiliates of Artal will be the selling shareholder under any offering of common stock pursuant to this prospectus. As of the date
of this prospectus, Artal Luxembourg S.A., an indirect subsidiary of Artal, is the record holder of all our shares owned by Artal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional information about the selling shareholder will be set forth in a prospectus supplement, in a post-effective amendment or in filings
we will make with the SEC that are incorporated by reference into this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom582596_8"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our authorized capital stock consists of (1)&nbsp;1.0&nbsp;billion shares of common stock, no par value, and (2)&nbsp;250,000,000 shares of
preferred stock, no par value. Subject to the rights of our Board of Directors as described below, our authorized preferred stock currently consists of 1,000,000 shares designated as Series A Preferred Stock and 10,000,000 shares designated as
Series B Junior Participating Preferred Stock (&#147;Series B Preferred Stock&#148;). No shares of preferred stock are issued or outstanding as of the date of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following description of our capital stock and related matters is qualified in its entirety by reference to our articles of incorporation
and bylaws, copies of which are filed as exhibits to the registration statement of which this prospectus forms a part. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Voting Rights. </I>The holders of our common stock are entitled to one vote per share on all matters submitted for action by the
shareholders. There is no provision for cumulative voting with respect to the election of directors. Accordingly, a holder of more than 50% of the shares of our common stock can, if it so chooses, elect all of our directors. In that event, the
holders of the remaining shares will not be able to elect any directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Dividend Rights.</I>&nbsp;All shares of our common stock are
entitled to share equally in any dividends our Board of Directors may declare from legally available sources. The covenants in our existing indebtedness, including our credit facilities and the indenture governing our 8.625% Senior Notes due 2025,
impose certain restrictions on our ability to declare dividends with respect to our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Liquidation Rights.</I>&nbsp;Upon
liquidation or dissolution of the Company, whether voluntary or involuntary, all shares of our common stock are entitled to share equally in the assets available for distribution to shareholders after payment of all of our prior obligations,
including our preferred stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Other Matters.</I>&nbsp;The holders of our common stock have no preemptive or conversion rights and our
common stock is not subject to further calls or assessments by us. There are no redemption or sinking fund provisions applicable to the common stock. All outstanding shares of our common stock, including the common stock offered in this offering,
are fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> The rights, powers, preferences and privileges of holders of our common stock will be subject to those of the holders of any shares of our preferred stock we may authorize
and issue in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors has the authority, without any further vote or action by our shareholders, to designate and issue preferred stock in one
or more series and to designate the rights, preferences and privileges of each series, which may be greater than the rights of our common stock. It is not possible to state the actual effect of the issuance of any series of preferred stock upon the
rights of holders of our common stock until our Board of Directors determines the specific rights of the holders of that series. However, the effects might include, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">restricting dividends on the common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">diluting the voting power of the common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">impairing the liquidation rights of the common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delaying or preventing a change in control without further action by the shareholders; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">impeding or discouraging an acquisition attempt or other transaction that some, or a majority, of the holders of our common stock might believe to be in their best interests or in which the holders of our common stock
might receive a premium for their common stock over the market price of the common stock. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of these or other factors, the issuance of preferred stock may have an adverse
impact on the market price of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors has designated two series of preferred stock (Series A Preferred
Stock and Series B Preferred Stock) of which no shares are issued and outstanding. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series A Preferred Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Rank.</I><B> </B>The Series A Preferred Stock, with respect to dividend rights and rights on liquidation, winding up and dissolution, ranks
senior to our common stock, our Series B Preferred Stock and all other classes and series of capital stock of the Company, which by their terms expressly provide that they are junior to the Series A Preferred Stock. The Series A Preferred Stock
ranks on a parity with each other class or series of capital stock the terms of which specifically provide that such class or series will rank on a parity with the Series A Preferred Stock and junior to each other class or series of capital stock
the terms of which specifically provide that such class or series will rank senior to the Series A Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Voting Rights.
</I>The holders of the Series A Preferred Stock generally have no voting rights with respect to their shares of Series A Preferred Stock, except with respect to an amendment, repeal or change in any of the provisions of the Company&#146;s articles
of incorporation or bylaws that would adversely affect the rights of the holders of the Series A Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Dividend Rights.
</I>The holders of shares of the Series A Preferred Stock are entitled to receive, as and when declared and out of funds legally available therefor, dividends in cash on each share of Series A Preferred Stock at an annual rate equal to 6% of the
Liquidation Value (as defined below). Such dividends are cumulative and will accrue and be payable annually in preference to dividends on any securities junior to the Series A Preferred Stock, including our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">So long as any shares of the Series A Preferred Stock are outstanding, the Company may not purchase, redeem or retire any securities junior to
the Series A Preferred Stock, including our common stock, subject to certain exceptions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Liquidation Rights.</I> The liquidation
preference of the Series A Preferred Stock is $25.00 per share (the &#147;Liquidation Value&#148;). In the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the holders of shares of Series A
Preferred Stock then outstanding are entitled to be paid out of the assets of the Company available for distribution to its shareholders an amount in cash equal to 100% of the Liquidation Value for each share outstanding, plus an amount in cash
equal to all accrued but unpaid dividends thereon to the date of liquidation, dissolution or winding up, before any payment will be made or any assets distributed to the holders of any securities junior to the Series A Preferred Stock, including our
common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Redemption</I>. The Company may redeem, in whole or in part, the Series A Preferred Stock, at any time or from time to
time at a price per share equal to 100% of the Liquidation Value thereof plus 100% of the sum of accrued and unpaid dividends thereon (including an amount equal to a prorated dividend from the last dividend payment date immediately prior to the
redemption date). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the occurrence of a change in control or a public offering of our common stock by Artal Luxembourg S.A., the
Series A Preferred Stock is redeemable at the option of the holders thereof, in whole or in part at a redemption price per share payable in cash equal to 100% of the Liquidation Value plus accrued and unpaid dividends to the date of redemption
(including an amount equal to a prorated dividend from the last dividend payment date immediately prior to the redemption date). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series B Preferred Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Ranking</I>. The Series B Preferred Stock ranks senior to our common stock and junior to our Series A Preferred Stock and all other series
of the Company&#146;s preferred stock, in each case as to the payment of dividends and the distribution of assets, unless the terms of any such other series provides otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Voting rights.</I> Subject to certain adjustments, each share of Series B Preferred Stock entitles the holder thereof to 100 votes on all
matters submitted to a vote of our shareholders. The holders of shares of Series B Preferred Stock and the holders of shares of our common stock vote together as one class on all matters submitted to a vote of our shareholders. If at any time
dividends on any Series B Preferred Stock is in arrears in an amount equal to six quarterly dividends thereon, holders of the Series B Preferred Stock will have certain rights, including the right to elect two directors, until such time when all
accrued and unpaid dividends have been declared and paid or set apart for payment. Subject to certain exceptions or as otherwise provided by law, holders of Series B Preferred Stock have no special voting rights, and their consent will not be
required (except to the extent they are entitled to vote with holders of our common stock) for taking any corporate action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Dividend
Rights.</I> Subject to certain adjustments and any prior and superior rights of the holders of any shares of any series of Preferred Stock ranking prior and superior to the shares of Series B Preferred Stock with respect to dividends, the holders of
shares of Series B Preferred Stock are entitled to receive, in preference to the holders of our common stock and any other capital stock of the Company ranking junior to the Series B Preferred Stock, when, as and if declared by our Board of
Directors, quarterly dividends payable in cash on the fifteenth day of January, April, July and October in each year, in an amount per share (rounded to the nearest cent) equal to the greater of (a) $0.01 or (b) 100 times the aggregate per share
amount of all cash dividends plus 100 times the aggregate per share amount (payable in kind) of all <FONT STYLE="white-space:nowrap">non-cash</FONT> dividends or other distributions (other than a dividend payable in shares of our common stock or a
subdivision of the outstanding shares of our common stock) declared on our common stock, subject to certain adjustment provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company must declare a dividend or distribution on the Series B Preferred Stock immediately after it declares a dividend or distribution on our common stock (other than a dividend payable in shares of our common stock). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Liquidation Rights.</I> Upon any liquidation (voluntary or otherwise), dissolution or winding up of the Company, no distribution will be
made to the holders of shares of our capital stock ranking junior (either as to dividends or upon liquidation, dissolution or winding up) to the Series B Preferred Stock unless, prior thereto, the holders of shares of Series B Preferred Stock have
received $1.00 per share, plus an amount equal to accrued and unpaid dividends and distributions thereon, whether or not declared, to the date of such payment (the &#147;Series B Liquidation Preference&#148;). Following the payment of the full
amount of the Series B Liquidation Preference, no additional distributions will be made to the holders of shares of Series B Preferred Stock unless, prior thereto, the holders of shares of our common stock have received an amount per share (the
&#147;Common Adjustment&#148;) equal to the quotient obtained by dividing (i)&nbsp;the Series B Liquidation Preference by (ii) 100 (as appropriately adjusted to reflect such events as stock splits, stock dividends and recapitalizations with respect
to our common stock) (such number in clause (ii), the &#147;Adjustment Number&#148;). Following the payment of the full amount of the Series B Liquidation Preference and the Common Adjustment in respect of all outstanding shares of Series B
Preferred Stock and our common stock, respectively, holders of Series B Preferred Stock and holders of shares of our common stock will receive their ratable and proportionate share of the remaining assets to be distributed in the ratio of the
Adjustment Number to one with respect to such Series B Preferred Stock and common stock, on a per share basis, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the
event, however, that there are not sufficient assets available to permit payment in full of the Series B Liquidation Preference and the liquidation preferences of all other series of preferred stock, if any, that rank on a parity with the Series B
Preferred Stock, then such remaining assets will be distributed ratably to the holders of the Series B Preferred Stock and such parity shares in proportion to their respective liquidation preferences. In
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the event, however, that there are not sufficient assets available to permit payment in full of the Common Adjustment, then such remaining assets will be distributed ratably to the holders of our
common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Certain Restrictions</I>. Whenever quarterly dividends or other dividends or distributions payable on the Series B
Preferred Stock are in arrears, thereafter and until all accrued and unpaid dividends and distributions, whether or not declared, on shares of Series B Preferred Stock outstanding have been paid in full, the Company may not declare or pay dividends
on, or redeem or purchase, any shares of capital stock ranking junior to the Series B Preferred Stock (including our common stock), subject to certain exceptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Consolidation, Merger, etc. </I>Subject to certain adjustments, if the Company enters into any consolidation, merger, statutory share
exchange or other transaction in which the shares of our common stock are converted into, exchanged for or changed into other stock or securities, cash and/or any other property, then in any such case the shares of Series B Preferred Stock will at
the same time be similarly converted into, exchanged for or changed in an amount per share (subject to certain adjustments ) equal to 100 times the aggregate amount of stock, securities, cash and/or any other property (payable in kind), as the case
may be, into which or for which each share of our common stock is changed or exchanged. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>No Redemption.</I> The shares of Series B
Preferred Stock are not redeemable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Authorized but Unissued Capital Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The listing requirements of the NYSE, which will apply so long as our common stock remains listed on the NYSE, require shareholder approval of
certain issuances equal to or exceeding 20% of then-outstanding voting power or then-outstanding number of shares of common stock. These additional shares may be used for a variety of corporate purposes, including future public offerings, to raise
additional capital or to facilitate acquisitions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the effects of the existence of unissued and unreserved common stock or
preferred stock may be to enable our Board of Directors to issue shares to persons friendly to current management, which issuance could render more difficult or discourage an attempt to obtain control of our company by means of a merger, tender
offer, proxy contest or otherwise, and thereby protect the continuity of our management and possibly deprive the shareholders of opportunities to sell their shares of common stock at prices higher than prevailing market prices. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Provisions of Virginia Law and Our Articles of Incorporation and Bylaws </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some provisions of Virginia law and our articles of incorporation and bylaws could make the following more difficult: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">acquisition of us by means of a tender offer; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">acquisition of us by means of a proxy contest or otherwise; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">removal of our incumbent officers and directors. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These provisions, summarized below, are
intended to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board. We believe that the benefits of increased
protection give us the potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us and outweigh the disadvantages of discouraging these proposals because negotiation of these proposals
could result in an improvement of their terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Election and Removal of Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors is divided into three classes. The directors in each class will serve for a three-year term, one class being elected
each year by our shareholders. This system of electing and removing directors may discourage a third party from making a tender offer or otherwise attempting to obtain control of us because it generally makes it more difficult for shareholders to
replace a majority of our directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our articles of incorporation and bylaws do not provide for cumulative voting in the
election of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time that Artal or certain of its transferees beneficially owns a majority of our then outstanding common
stock, directors may be removed with or without cause. At all other times, directors may be removed only with cause. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Board Meetings
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our bylaws provide that the chairman of the board or any two of our directors may call special meetings of the Board of Directors.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Shareholder Meetings </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our articles of incorporation provide that special meetings of shareholders may be called by the chairman of our Board of Directors or our
president or by our Board of Directors. In addition, our articles of incorporation provide that Artal and certain of its transferees have the right to call special meetings of shareholders prior to the date it ceases to beneficially own 20% of our
then outstanding common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Requirements for Advance Notification of Shareholder Nominations and Proposals </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our bylaws establish advance notice procedures with respect to shareholder proposals and the nomination of candidates for election as
directors, other than nominations made by or at the direction of our Board of Directors or a committee of the Board of Directors or by Artal and certain of its transferees when nominating its director designees. In addition, our bylaws provide that
so long as Artal or certain of its transferees beneficially owns a majority of our then outstanding common stock, the foregoing advance notice procedures for shareholder proposals will not apply to it. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Shareholder Action by Written Consent </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Virginia law generally requires shareholder action to be taken only at a meeting of shareholders and permits shareholders of a public
corporation to act only by written consent with the unanimous written consent of all shareholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Amendment of Articles of
Incorporation and Bylaw Provisions </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Amendment of the provisions described under &#147;&#151;Election and Removal of Directors&#148;
and &#147;&#151;Shareholder Meetings&#148; above and the provisions described under this &#147;&#151;Amendment of Articles of Incorporation and Bylaw Provisions&#148; in our articles of incorporation generally will require an affirmative vote of our
directors, as well as the affirmative vote of at least 80% of our then outstanding voting stock, except that at any time that Artal or certain of its transferees beneficially owns a majority of our then outstanding common stock, such provisions of
our articles of incorporation may be amended by the affirmative vote of a majority of our then outstanding voting stock. Amendments to any other provisions of our articles of incorporation generally require the affirmative vote of a majority of our
then outstanding voting stock. Our bylaws may be amended by the affirmative vote of our directors or by the affirmative vote of at least 80% of our then outstanding voting stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Liability of Officers and Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our articles of incorporation require us to indemnify any director, officer or employee who was or is a party to any claim, action or
proceeding by reason of his being or having been a director, officer or employee of our company or any other corporation, entity or plan while serving at our request, unless he or she engaged in willful misconduct or a knowing violation of criminal
law. Insofar as indemnification of directors, officers or persons controlling us for liabilities arising under the Securities Act of 1933 may be permitted pursuant to the foregoing provisions, we have been informed that, in the opinion of the SEC,
indemnification for liabilities under the Securities Act is against public policy and is unenforceable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Anti-Takeover Statutes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have opted out of the Virginia anti-takeover law regulating &#147;control share acquisitions.&#148; Under Virginia law, shares acquired in a
control share acquisition have no voting rights unless granted by a majority vote of all outstanding shares other than those held by the acquiring person or any officer or employee director of the corporation, or the articles of incorporation or
bylaws of the corporation provide that this regulation does not apply to acquisitions of its shares. An acquiring person that owns five percent or more of the corporation&#146;s voting stock may require that a special meeting of the shareholders be
held, within 50&nbsp;days of the acquiring person&#146;s request, to consider the grant of voting rights to the shares acquired in the control share acquisition. If voting rights are not granted and the corporation&#146;s articles of incorporation
or bylaws permit, the acquiring person&#146;s shares may be repurchased by the corporation, at its option, at a price per share equal to the acquiring person&#146;s cost. Virginia law grants appraisal rights to any shareholder who objects to a
control share acquisition that is approved by a vote of disinterested shareholders and that gives the acquiring person control of a majority of the corporation&#146;s voting shares. This regulation was designed to deter certain takeovers of Virginia
public corporations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have opted out of the Virginia anti-takeover law regulating &#147;affiliated transactions.&#148; Under this law,
certain material transactions between a Virginia corporation and any holder of more than 10% of any class of its outstanding voting shares are required to be approved by the holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of
the remaining voting shares. Affiliated transactions subject to this approval requirement include mergers, share exchanges, material dispositions of corporate assets not in the ordinary course of business, any dissolution of the corporation proposed
by or on behalf of a 10% holder or any reclassification, including reverse stock splits, recapitalization or merger of the corporation with its subsidiaries, that increases the percentage of voting shares owned beneficially by a 10% holder by more
than five percent. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registrar and Transfer Agent </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registrar and transfer agent for the common stock is Computershare Trust Company, N.A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on
the NYSE under the symbol &#147;WTW.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom582596_9"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling shareholder may sell the shares of our common stock covered by this prospectus in any of the following ways (or in any
combination): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to or through underwriters, brokers or dealers (acting as agent or principal); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">through a block trade in which the broker or dealer engaged to handle the block trade will attempt to sell the securities as an agent, but may position and resell a portion of the block as principal to facilitate the
transaction; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">directly to one or more purchasers, including through a specific bidding or auction process or otherwise; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">directly to or through agents; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in &#147;at the market offerings,&#148; within the meaning of Rule 415(a)(4) of the Securities Act; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">through a combination of any of these methods of sale; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">through any other methods described in a prospectus supplement. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The distribution of
securities may be effected from time to time in one or more transactions, including block transactions and transactions on the NYSE or any other organized market where the securities may be traded. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each time that the selling shareholder sells shares of our common stock covered by this prospectus, we will provide a prospectus supplement
that will describe the method of distribution and set forth the terms and conditions of the offering of such shares, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the name or names of any underwriters, dealers, brokers or agents and the amounts of shares underwritten or purchased by each of them; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the offering price of the shares and any underwriting discounts, commissions, concessions or agency fees allowed or reallowed or paid to dealers, and other items constituting underwriters&#146;, dealers&#146;,
brokers&#146; or agents&#146; compensation, as applicable; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any options under which underwriters may purchase additional shares from the selling shareholder; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any securities exchange or market on which the shares may be listed or traded. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any offering
price and any discounts, commissions, concessions or agency fees allowed or reallowed or paid to dealers may be changed from time to time. The selling shareholder may determine the price or other terms of the shares of our common stock offered under
this prospectus by use of an electronic auction. We will describe how any auction will determine the price or any other terms, how potential investors may participate in the auction and the nature of the obligations of the underwriter, dealer or
agent in the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the selling shareholder sells securities to a dealer acting as a principal, the dealer
may resell such securities at varying prices to be determined by such dealer in its discretion at the time of resale without consulting with the selling shareholder and such resale prices may not be disclosed in the applicable prospectus supplement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling shareholder may distribute the shares from time to time in one or more transactions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">at a fixed price or at prices that may be changed from time to time; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">at market prices prevailing at the time of sale; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">at prices relating to such prevailing market prices; or </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">at negotiated prices. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any of the prices may represent a discount of then-prevailing market
prices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters, dealers or any other third parties described above may offer and sell the offered shares from time to time in one
or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale. If underwriters or dealers are used in the sale of any shares, the shares will be acquired by the
underwriters or dealers for their own account and may be resold from time to time in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale. The shares may be
either offered to the public through underwriting syndicates represented by managing underwriters, or directly by underwriters. Generally, the underwriters&#146; obligations to purchase the shares will be subject to certain conditions precedent. The
underwriters will be obligated to purchase all of the shares if they purchase any of the shares (other than any shares purchased upon exercise of any option to purchase additional shares), unless otherwise specified in the prospectus supplement. The
selling shareholder may use underwriters with whom we have a material relationship. We will describe the nature of any such relationship in the prospectus supplement, naming the underwriter or underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling shareholder may sell the shares through agents from time to time. The prospectus supplement will name any agent involved in the
offer or sale of the shares and any commissions paid to them. Generally, any agent will be acting on a best efforts basis for the period of its appointment. The selling shareholder may engage in <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">at-the-market</FONT></FONT> offerings into an existing trading market in accordance with Rule 415(a)(4) under the Securities Act. The selling shareholder may authorize underwriters, dealers, brokers or agents to solicit
offers by certain purchasers to purchase the shares from the selling shareholder at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the
future. These contracts will be subject only to those conditions set forth in the prospectus supplement, and the prospectus supplement will set forth any commissions to be paid for solicitation of these contracts. Any underwriters, dealers, brokers
and agents that participate in the distribution of the shares may be deemed to be &#147;underwriters&#148; as defined in the Securities Act. Any commissions paid or any discounts or concessions allowed to any such persons, and any profits they
receive on resale of the shares, may be deemed to be underwriting discounts and commissions under the Securities Act. We will identify any underwriters or agents and describe their compensation in a prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Offered shares may also be offered and sold, if so indicated in the applicable prospectus supplement, in connection with a remarketing upon
their purchase, in accordance with a redemption or repayment pursuant to their terms, or otherwise, by one or more marketing firms, acting as principals for their own accounts or as agents for the selling shareholder. Any remarketing firm will be
identified and the terms of its agreements, if any, with us and its compensation will be described in the applicable prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters or agents may purchase and sell the shares in the open market. These transactions may include over-allotments or short sales of
the securities, stabilizing transactions, syndicate covering transactions and penalty bids. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Over-allotment or short sales involve sales
by persons participating in the offering of more securities than were sold to them. In these circumstances, these persons would cover such over-allotments or short positions by making purchases in the open market or by exercising their
over-allotment option, if any. Stabilizing transactions consist of bids or purchases for the purpose of preventing or retarding a decline in the market price of the shares and are permitted so long as the stabilizing bids do not exceed a specified
maximum. Syndicate covering transactions involve the placing of any bid on behalf of the underwriting syndicate or the effecting of any purchase to reduce a short position created in connection with the offering. The underwriters or agents also may
impose a penalty bid, which permits them to reclaim selling concessions allowed to syndicate members or certain dealers if they repurchase the shares in stabilizing or covering transactions. These activities may stabilize, maintain or otherwise
affect the market price of the shares, which may be higher than the price that might </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
otherwise prevail in the open market. These activities, if begun, may be discontinued at any time. These transactions may be effected on any exchange on which the shares are traded, in the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is
listed on the NYSE under the symbol &#147;WTW&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If at the time of any offering made under this prospectus a member of the Financial
Industry Regulatory Authority (&#147;FINRA&#148;) participating in the offering has a &#147;conflict of interest&#148; as defined in FINRA&#146;s Rule 5121 (&#147;Rule 5121&#148;), that offering will be conducted in accordance with the relevant
provisions of Rule 5121. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling shareholder may also sell securities under Rule 144 of the Securities Act, if available, or pursuant
to other available exemptions from registration requirements under the Securities Act, rather than under this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Agents,
dealers, brokers and underwriters may be entitled to indemnification by us and the selling shareholder, against certain civil liabilities, including liabilities under the Securities Act, or to contribution with respect to payments which the agents,
dealers, brokers or underwriters may be required to make in respect thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The specific terms of the
<FONT STYLE="white-space:nowrap">lock-up</FONT> provisions in respect of any given offering will be described in the applicable prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom582596_10"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless we state otherwise in the applicable prospectus supplement, the validity of the shares of common stock offered hereunder will be passed
upon for us by our special Virginia counsel, Hunton Andrews Kurth LLP, Richmond, Virginia. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom582596_11"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements and management&#146;s assessment of the effectiveness of internal control over financial reporting (which is included
in Management&#146;s Annual Report on Internal Control over Financial Reporting) incorporated in this Prospectus by reference to the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;30, 2017 have
been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom582596_12"></A>WHERE YOU CAN FIND ADDITIONAL INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC. You may access and read our SEC filings,
including the complete registration statement and all of the exhibits to it, through the SEC&#146;s Internet site at&nbsp;www.sec.gov. This site contains reports and other information that we file electronically with the SEC. You may also read and
copy any document we file at the SEC&#146;s public reference room located at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-732-0330</FONT></FONT></FONT> for further information on the public reference room. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement under the Securities Act with respect to the common stock offered by this prospectus. This
prospectus, which constitutes part of the registration statement, does not contain all of the information presented or incorporated by reference into the registration statement and its exhibits and schedules. Our descriptions contained in or
incorporated by reference into this prospectus of the provisions of documents filed as exhibits to the registration statement or otherwise filed with the SEC are only summaries of the terms of those documents that we consider material. If you want a
complete description of the content of the documents, you should obtain the documents yourself by following the procedures described above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may request copies of any of our filings, at no cost, by telephone at <FONT STYLE="white-space:nowrap">(212)&nbsp;589-2700;</FONT> by mail
at: 675 Avenue of the Americas, 6th Floor, New York, New York 10010, Attention: Secretary; or by visiting http://www.weightwatchersinternational.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom582596_13"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; information into this prospectus. This means that we can disclose important
information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is considered to be part of this prospectus, except for any information that is superseded by information that is
included directly in this document or in a more recent incorporated document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus incorporates by reference the documents
listed below that we have previously filed with the SEC. The documents contain important information about us and our financial condition. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our annual report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year ended December&nbsp;30, 2017, filed February&nbsp;28, 2018; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our quarterly report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarterly period ended March&nbsp;31, 2018, filed May 4, 2018; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our current report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on March&nbsp;9, 2018; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the portions of our Definitive Proxy Statement on Schedule 14A, filed April&nbsp;5, 2018, that are incorporated by reference into our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal
year ended December&nbsp;30, 2017; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the description of our common stock contained in our Registration Statement on Form <FONT STYLE="white-space:nowrap">8-A</FONT> filed on November&nbsp;9, 2001 and amended on January&nbsp;6, 2012, including all
amendments and reports filed for the purpose of updating such description. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We incorporate by reference any future filings
we make with the SEC under Section&nbsp;13(a), 13(c), 14, or 15(d) of the Securities Exchange Act of 1934 between the date of this prospectus and the date all of the securities offered hereby are sold (other than any portions thereof that are
furnished and not filed and exhibits relating to such disclosures, unless otherwise specifically stated in such Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You can obtain any of the documents incorporated by reference into this prospectus from us, or from the SEC through the SEC&#146;s Internet
world wide website as described above. Documents incorporated by reference are available from us without charge, excluding any exhibits to those documents, unless the exhibit is specifically incorporated by reference into this prospectus. We will
deliver, without charge to the requester, to anyone receiving this prospectus including any beneficial owner, upon written or oral request, a copy of any or all of the information incorporated by reference into this prospectus but not delivered with
this prospectus, but the exhibits to those documents will not be delivered unless they have been specifically incorporated by reference. You can obtain documents incorporated by reference into this prospectus by requesting them in writing or by
telephone from us as described above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:138pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g582596g89e43.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:250pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is May 7, 2018. </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;14. Other Expenses of Issuance and Distribution. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The estimated expenses in connection with the offering (other than underwriting discounts and commissions) that will be borne by Weight
Watchers International, Inc. are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC Registration Fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accountants&#146; Fees and Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal Fees and Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer Agent and Registrar Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing and Duplicating Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Omitted because the registration fee is being deferred pursuant to Rule 456(b). </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top">Estimated expenses are not presently known. To the extent required, any applicable prospectus supplement or one more current reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> will set forth the estimated
aggregate amount of expenses payable in respect of any offering of securities. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;15. Indemnification of Directors and Officers.
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Weight Watchers International, Inc. is a Virginia corporation. The Virginia Stock Corporation Act (the &#147;VSCA&#148;) permits a
Virginia corporation to indemnify its directors and officers in a variety of circumstances, which may include indemnification for liabilities under the Securities Act. Under the VSCA, a corporation generally is authorized to indemnify its directors
and officers in civil and criminal actions if they acted in good faith and believed their conduct to be in the best interests of the corporation and, in the case of criminal actions, had no reasonable cause to believe that the conduct was unlawful.
The VSCA requires such indemnification, unless limited by a corporation&#146;s articles of incorporation, when a director or officer entirely prevails in the defense of any proceeding to which he or she was a party because he or she is or was a
director or officer of the corporation. The VSCA provides that a corporation may make any other or further indemnity (including indemnity with respect to a proceeding by or in the right of the corporation), and may make additional provision for
advances and reimbursement of expenses, if authorized by its articles of incorporation or shareholder-adopted bylaw or resolution, except an indemnity against willful misconduct or a knowing violation of the criminal law. The Registrant&#146;s
Amended and Restated Articles of Incorporation (the &#147;Articles&#148;) require indemnification of directors and officers with respect to certain liabilities and expenses imposed upon them by reason of having been a director or officer, except in
the case of willful misconduct or a knowing violation of criminal law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The VSCA establishes a statutory limit on liability of directors
and officers of a corporation for damages assessed against them in a suit brought by or in the right of the corporation or brought by or on behalf of the corporation&#146;s shareholders and authorizes a corporation to specify a lower monetary limit
on liability (including the elimination of liability for monetary damages) in the corporation&#146;s articles of incorporation or bylaws; however, the liability of a director or officer shall not be limited if such director or officer engaged in
willful misconduct or a knowing violation of the criminal law or of any federal or state securities law. As permitted by the VSCA, the Articles eliminate the liability for monetary damages of a director or officer in a proceeding brought by or in
the right of the Registrant or brought by or on behalf of the Registrant&#146;s shareholders. This elimination of liability will not apply in the event of willful misconduct or a knowing violation of criminal law or any federal or state securities
law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Registrant maintains officers&#146; and directors&#146; insurance covering certain liabilities that may be incurred by officers
and directors in the performance of their duties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;16. </B><B><I>Exhibits.</I></B><B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See Index to Exhibits, which is incorporated herein by reference. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;17. Undertakings. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
undersigned Registrant hereby undertakes: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;To file, during any period in which offers or sales are being made,
a post-effective amendment to this Registration Statement: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;To include any prospectus required
by Section&nbsp;10(a)(3) of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;To reflect in the prospectus any facts or events arising after the effective date of the
Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any
increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in
the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#147;Calculation of
Registration Fee&#148; table in the effective Registration Statement; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;To include any
material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided, however, that paragraphs (1)(i), (1)(ii) and (1)(iii) do not apply if the information required to be included in a post effective amendment by those
paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;) that are incorporated by reference
in the Registration Statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment
shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide </I>offering thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;To remove from registration by means of a post-effective amendment any of the securities being registered which
remain unsold at the termination of the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;That, for the purpose of determining liability under the
Securities Act to any purchaser: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Each prospectus filed by the Registrant pursuant to Rule
424(b)(3) shall be deemed to be part of the Registration Statement as of the date the filed prospectus was deemed part of and included in the Registration Statement; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a
Registration Statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x)&nbsp;for the purpose of providing the information required by section 10(a) of the Securities Act shall be deemed to be part of
and included in the Registration Statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in
Rule 430B, for liability purposes of the issuer and any person </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
that is at that date an underwriter, such date shall be deemed to be a new effective date of the Registration Statement relating to the securities in the Registration Statement to which that
prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; provided, however, that no statement made in a Registration Statement or prospectus that is part of the Registration
Statement or made in a document incorporated or deemed incorporated by reference into the Registration Statement or prospectus that is part of the Registration Statement will, as to a purchaser with a time of contract of sale prior to such effective
date, supersede or modify any statement that was made in the Registration Statement or prospectus that was part of the Registration Statement or made in any such document immediately prior to such effective date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;That, for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the
initial distribution of the securities: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned Registrant undertakes that in a primary offering of securities of the undersigned Registrant
pursuant to this Registration Statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned
Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering
required to be filed pursuant to Rule 424; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Any free writing prospectus relating to the
offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;The portion of any other free writing prospectus relating to the offering containing material
information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;Any other communication that is an offer in the offering made by the undersigned Registrant to the
purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each
filing of the Registrant&#146;s annual report pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#146;s annual report pursuant to Section&nbsp;15(d) of the Exchange Act) that
is incorporated by reference in the Registration Statement shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide
</I>offering thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers
and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in
the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the
Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEX TO EXHIBITS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:28.45pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:78.55pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description of
Exhibits</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;1.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Underwriting Agreement<SUP STYLE="font-size:85%; vertical-align:top">*</SUP></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/105319/000119312512005143/d278682dex31.htm">Amended and Restated Articles of Incorporation of Weight Watchers International, Inc. (incorporated by reference to Exhibit 3.1 to Amendment No.&nbsp;1
to the Company&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">8-A,</FONT> as filed on January&nbsp;6, 2012 (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-16769))</FONT> </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/105319/000119312512005143/d278682dex32.htm">Articles of Amendment to the Articles of Incorporation, as Amended and Restated, of Weight Watchers International, Inc. to Create a New Series
 of Preferred Stock Designated as Series B Junior Participating Preferred Stock, adopted as of November&nbsp;14, 2001 (incorporated by reference to Exhibit 3.2 to Amendment No.&nbsp;1 to the Company&#146;s Registration Statement on Form <FONT
STYLE="white-space:nowrap">8-A,</FONT> as filed on January&nbsp;6, 2012 (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-16769))</FONT></A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/105319/000119312513445697/d630068dex31.htm">Amended and Restated Bylaws of Weight Watchers International, Inc., as of November&nbsp;
14, 2013 (incorporated by reference to Exhibit 3.1 to the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> as filed on November&nbsp;18, 2013 (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-16769))</FONT>
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/105319/000119312512005143/d278682dex41.htm">Specimen of stock certificate representing Weight Watchers International, Inc.&#146;s common stock, no par value (incorporated by reference to
 Exhibit 4.1 to Amendment No.&nbsp;1 to the Company&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">8-A,</FONT> as filed on January&nbsp;6, 2012 (File <FONT STYLE="white-space:nowrap">No.&nbsp;001-16769))</FONT> </A></TD></TR>

<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d582596dex51.htm">Opinion of Hunton Andrews Kurth LLP<SUP STYLE="font-size:85%; vertical-align:top">**</SUP> </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d582596dex231.htm">Consent of PricewaterhouseCoopers LLP<SUP STYLE="font-size:85%; vertical-align:top">**</SUP> </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d582596dex51.htm">Consent of Hunton Andrews Kurth LLP (contained in Exhibit 5.1)<SUP STYLE="font-size:85%; vertical-align:top">**</SUP> </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ii582596_111">Power of Attorney*** </A></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">To be filed, if necessary, by amendment or as an exhibit to a current report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> and incorporated by reference herein. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top">Filed herewith </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">***</TD>
<TD ALIGN="left" VALIGN="top">Included on the signature page to this Registration Statement. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="ii582596_111"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form <FONT STYLE="white-space:nowrap">S-3</FONT> and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New
York, on the 7th day of May, 2018. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">WEIGHT WATCHERS INTERNATIONAL, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mindy Grossman</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Mindy Grossman</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President, Chief Executive Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(Principal Executive Officer)</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">KNOW ALL MEN BY THESE PRESENT, that each person whose signature appears below hereby constitutes and
appoints Mindy Grossman, Nicholas P. Hotchkin or any of them, his or her true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, with full power of substitution and
resubstitution, for him or her and in his or her name, place and stead, in any and all capacities to sign any and all amendments to the Registration Statement, including post-effective amendments, and to file the same, with all exhibits thereto, and
other documents in connection therewith, with the Securities and Exchange Commission, and does hereby grant unto said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, and each of them,
full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all
that said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, or any of them, or their or his or her substitutes, may lawfully do or cause to be done by virtue hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act, as amended, this Registration Statement has been signed below by the following persons in
the capacities indicated on the 7th day of May, 2018. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="53%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:33.30pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:15.95pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mindy Grossman</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Mindy Grossman</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">President, Chief Executive Officer and Director <BR><B>(Principal Executive Officer)</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Nicholas P. Hotchkin</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Nicholas P. Hotchkin</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Chief Financial Officer and President, Emerging Markets<BR>(<B>Principal Financial and Accounting Officer</B>)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Raymond Debbane</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Raymond Debbane</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Steven M. Altschuler</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Steven M. Altschuler</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Philippe J. Amouyal</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Philippe J. Amouyal</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Cynthia Elkins</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Cynthia Elkins</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jonas M. Fajgenbaum</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Jonas M. Fajgenbaum</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">v </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="53%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:33.30pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:15.95pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Denis F. Kelly</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Denis F. Kelly</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sacha Lainovic</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sacha Lainovic</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Thilo Semmelbauer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Thilo Semmelbauer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher J. Sobecki</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Christopher J. Sobecki</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Oprah Winfrey</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Oprah Winfrey</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">vi </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d582596dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">


<IMG SRC="g582596snap111.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">HUNTON ANDREWS KURTH LLP</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">RIVERFRONT PLAZA,
EAST TOWER<BR>951 EAST BYRD STREET<BR>RICHMOND, VIRGINIA 23219-4074</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">TEL&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;804 &#149; 788 &#149; 8200<BR>FAX&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;804 &#149; 788 &#149;
8218</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">File No: 56980.000017</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May 7, 2018 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Weight Watchers
International, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">675 Avenue of the Americas, 6<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10010 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Weight Watchers
International, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as special
Virginia counsel for Weight Watchers International, Inc., a Virginia corporation (the &#147;Company&#148;), in connection with the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> filed by the Company with the Securities
and Exchange Commission (the &#147;Commission&#148;) on the date hereof (the &#147;Registration Statement&#148;) pursuant to the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). The Registration Statement relates to the offer and
sale by one or more of the affiliates of Artal Group S.A. (collectively, the &#147;Selling Shareholder&#148;) of an indeterminate number of shares of the Company&#146;s common stock, no par value (the &#147;Common Stock&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of Common Stock will be offered and sold on a continuous or delayed basis pursuant to Rule 415 of the Securities Act from time to
time as set forth in the Registration Statement, the prospectus contained therein (the &#147;Prospectus&#148;) and any amendments or supplements thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is being furnished in accordance with the requirements of Item 16 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> and Item
601(b)(5)(i) of Regulation <FONT STYLE="white-space:nowrap">S-K.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the opinion expressed below, we have relied upon,
among other things, our examination of such documents and records of the Company and certificates of its officers and of public officials as we deemed necessary, including (i)&nbsp;the Company&#146;s Amended and Restated Articles of Incorporation,
as amended through the date hereof, (ii)&nbsp;the Company&#146;s Amended and Restated Bylaws, as amended through the date hereof, (iii)&nbsp;the Registration Statement, (iv)&nbsp;resolutions of the Company&#146;s Board of Directors and (v)&nbsp;a
certificate issued by the Clerk of the State Corporation Commission of the Commonwealth of Virginia on the date hereof to the effect that the Company is existing under the laws of the Commonwealth of Virginia and in good standing. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Weight Watchers International, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May 7, 2018 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the opinions expressed below, we have assumed (i)&nbsp;the authenticity of
all documents submitted to us as originals, (ii)&nbsp;the conformity to the originals of all documents submitted to us as copies and the authenticity of the originals thereof, (iii)&nbsp;the legal capacity of natural persons, (iv)&nbsp;the
genuineness of signatures not witnessed by us, (v)&nbsp;the due authorization, execution and delivery of all documents by all parties and (vi)&nbsp;the validity, binding effect and enforceability of all documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As to factual matters, we have relied upon representations included in the documents submitted to us, upon certificates of officers of the
Company and upon certificates of public officials.&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not purport to express an opinion on any laws other than
the laws of the Commonwealth of Virginia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing and such other information and documents as we have considered
necessary for the purposes hereof, and subject to the assumptions, qualifications and limitations noted herein, we are of the opinion that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;The Company is a corporation validly existing and in good standing under the laws of the Commonwealth
of Virginia. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;When (a)&nbsp;the Board of Directors of the Company or a duly constituted and
acting committee thereof (such Board of Directors or committee being hereinafter referred to as the &#147;Board&#148;) has taken all necessary corporate action to authorize and approve the issuance of shares of Common Stock from the then authorized
number of shares of Common Stock available and (b)&nbsp;such shares of Common Stock have been duly issued by the Company and delivered in accordance with the applicable definitive purchase, underwriting or similar agreement approved by the Board
upon payment of the consideration therefor, such Common Stock will be validly issued, fully paid and nonassessable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We consent to the
filing of this opinion as Exhibit 5.1 to the Registration Statement referred to above and to the reference to this firm under the heading &#147;Legal Matters&#148; in the Prospectus. In giving this consent, we do not admit that we are within the
category of persons whose consent is required by Section&nbsp;7 of the Securities Act or the rules and regulations promulgated thereunder by the Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is limited to the matters stated herein and no opinion is implied or may be inferred beyond the matters expressly stated. This
opinion is expressed as of the date hereof, </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Weight Watchers International, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May 7, 2018 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 3 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and we do not assume any obligation to advise you of facts or circumstances that hereafter come to our attention, or of changes in law that hereafter occur, which could affect the opinions
contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Very truly yours, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">/s/ Hunton Andrews Kurth LLP </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d582596dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the incorporation by reference in this Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> of Weight Watchers
International, Inc. of our report dated February&nbsp;28, 2018 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in Weight Watchers International,
Inc.&#146;s Annual Report on Form 10 K for the year ended December&nbsp;30, 2017. We also consent to the reference to us under the heading &#147;Experts&#148; in such Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ PricewaterhouseCoopers LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May 7, 2018 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g582596g72v68.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g582596g72v68.jpg
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ML!Q^88XJM2)EJS:3.6G-8P;/$<?R5FDY'8(MUOM$TS2 Q %Y)YJ"HPZR2@&
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MU-7ZD7'&5YR]'N*_57]\L4+)UZX5M&0$'*2<M(1%1J+]@V$$P<(QDH?OYIE
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M2RGID;Y#\D3']E7_ -\51.8,F6#-&6,FY?M:GMLV4K];\A3YO,RA0EKC/O[
M_33,8 'THN9!1) O8I2(D(0I2E*!0^@VFT(=+TZCIM<8@H4ZU.+IC]G6A2%2
M1\2$!/S)X#7<N[.WWG9F/KU8DG^Y^7T'$DN/G2V];Z;08_P)4$'S:$?ODI[)
M]N;("HWHF,8ATV-:K(X5,0[<CT6ZR</7&SD2I2=HE(:,.=--THLE!\X\SU.4
M=!N:O8*-*B&&A68X-N_(K>SP 9#%-P,D[+DQUXY9,$J 7:T#695B7(!ZNP_
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GKS32-^])+(S.[?-F)XFU55 55"J.@50 !] .@XV/IGC/&=+A<?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g582596g89e43.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g582596g89e43.jpg
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M P0%!@< "!$)$A,*%!46%R$B&#$C0E$:,T%R)3(T-5=886*6E]36_\0 '0$
M 04! 0$!              0%!@<( P(!"?_$ $L1  (! P(#!00&!@4("P
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MV&T57-]J:WTK2#/BLO==ZC?B1U8>>NJSS)]261?T78#Y@'!^>K=]N7J3=_\
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M5$LD\K'[4DKF1V^;,3\]2)0% 4;!0 !Y # _=I&+U1&X7Y[W:XEV\1C[S0^
M\8FGYUL13@&]]RZZ:R[QLY2*/!CMZ-7J&^:J*_FF2:=%3(0BISK:M[!K-[)P
M[<;RZXDN]>(8B1UI+<K1JRGUJIZM&QU[I<DD8$>N\O-.D0Z1)D_I2')_A5"/
MB>GBL5J]M-.C1HUZFC76SXVNE1R'2I9S 7&BV:#N%5G&9NUW$6*MR;:8AI)N
M8>0\S*09MW! , E,9,"G 2B("GJZ6"NI:FBJHUFIJN"6FJ(F^K)#/&T<J-Z,
MC$'XZ^JQ5@RG#*0P/D0<@_(ZU>-H6X>"W8[8\([BJ\1N@SRM0(6QOX]LH*R,
M)9RIFC;E6RJF,8RAJS;F$W **&,(G4C3'$?OK\^>([-+P]?;I99N8M;ZR6!'
M88,L&>>FGQX=_3/%,!Y.-3*"43PQRC[:@D>3=&7]5@1\M9Y?7(SFXSKU-=R+
MTKPSF#Q=/,,&UM 5!4)'-L6L$X&R-$S<\ 5;(/SG)F(4"@FK(*$$!,43FV3V
M4VI;3P+9%Y>66X1/=9STYVKW,L#'X4?LJ>H0:C-PD[RKE.=D/=CTY!@C]OF/
MSU4EJQ=(M&C1HT:--Z^E5W"^SM6YO:O*ON$IV'KV=J4R.IV)D?0+EM1<A&2(
M8>U9U(,IC'B@$3 %2MH-RJ8%$DS&0SCV_P!FYH+%?XTWBDFM-4X&?<E5JNCR
M?!4:.M&3MS2J-B1EZL\N&FA)Z@2*/4>Z_P R"GR4Z96ZENWN4W3;$=S>#J_&
M_%[5;,:OY&E18 'EDKQ27S"]TR.;F, @FXD;-68M@DH/ %,Y_,P$$VJ/X'O"
M6#BRQ769^[IZ>N1*J0]$I:I7I*ISZ)!/(Y_1\].U7$9J::,#+%,J/-E(=1\V
M4#4H<28\A\.XGQGBB!["0&+L>TW'T.(%!),L32JY'5UB;MYX3+[2-2,("/X_
M?D?W'3#<:V6Y7"NN$V\U?65-9+XGO*J=YW_B<Z[(@C1$7HBJH^"@ ?RTM!T&
M]Y(Y[WR]4.&=2@O6&8LB+[B<?MC+=P-:Q"WB?HRX( (CY4TZQ9<71H*@ "5&
M*0YY!0 +>7:UPU]$<*\!2!.1[;1"RUA QS5$M+#5C.-@3/!7N1ODR,1TTT6V
M?O*BK&?ZQN]7T 8J?W,@^7Y6][L]FY,\[U.G3N!/&D=1.VB[9EE+>J5,ICBW
MF\?)RN/EUS" B5.'R15X9RU.("5-5^NF42JNDS!6_#W$IM/#'&=G#E9+Y2VR
M.G&2!F*MY*P >)EHIY589W"@X(4C2Z>G[VHI9?"%I"WS4%#\G4>'CJR)PX0:
M(+NG2R39LV14<.'"ZA$D$$$2&466654$I$DDDRF.HH<Q2$(43&$  1U"@"Q"
MJ"S,0%4 DDDX  &Y).P W)TKUD^;W\^K[H]W6XC/JCA5PQR5E2TS-;%?O\S>
MDM'QH:A1ZGDX-W1E*C(".'DI/]E^R:8<)E_0?A6T"P\.66T!0KT-OIXY\8P:
MIE[VK<8_M*J29_UMR3OJ&U$O?3RR^#N2,_=Z*/DH U%C4@UQT:-&C1HT]MZ7
M/.ZMQVC9GP7*OP6=8-RXWFX5-98 "/I^7HA:28QZ)#&X*E\X5&^28F+P!E91
M4!#DO)LF]O5I%-Q';+K&F%NMN,4A ^O4VZ01NQ/G[-44B?!!J0VB3FADC)_J
MW!'HL@V_B5C\])+YLN2^1<S9;R"Z5%=U>\G7VY.5S&[S++V>U2LVLJ)A$1,*
MBCXQQ-R/<(\\_?6H[73"BMENHU&%I*"CIE V $%/'$ !X8":89&YY'?[SLW[
M1)_XZYCI?KQHT:-&C1JR+I&;A?TS=1';%D1X^]C6I:_M<971113QLBU3*J"U
M!D'LB/(<LJ^YGF-I-]Q$BT$@J!3BF!#0GM&LWT[P9?:)4YYXZ-JZE &7]HM[
M"L18_P <RPO3^HF89&<Z544O<U,+G8<P1O+E?W23Z#/-\M:AVL&ZEVH:]0[,
MOZ?MC>ZK+B3OV,E5,)7HE<==_C\5QL40M5:4/?R AW6V<A2<%$#CW=I![Q+J
M3<&VSZ8XJX?MQ7G2HNE(9EQG--#(*BJ_W>*4^0ZG;2>J?NZ:9_$1MC])ARK_
M !$:0JZ"&9?H[U/L!%=._:0F5DKAAJ;'O[/<?.E<>K59I]Q I_/D"'IX=AN>
M>.2 *@$#6M^UVV?27 EW*KS2V\TUSB_#[+.HJ&^5'+4_\=M1VW2=W5Q;[/S1
MG]93RC]L+_/6D_K$6I5JLWK"[A?TT].?<U>F;[V-FLE'6Q/3#)J>)[\RY872
MHI'D:?D.'T!$3,O:4A >2)P*JI2G,0"&G/9O9OISC2Q4C)SP0U8N%4",IW%O
M!JRL@^Y-)%'3GS,P&V<Z25TO=4LS>)7D7XO[NWP!)^6LP'6[]1+1HT:-&C1H
MT:L>Z?F\>=VE_5OX)*K1GS_\A>Y\2PH^?Y5^<_#W<"'=XOF17C^GD'^NH/QE
MPW%Q#]&][&LGL?MG+D#;VCV7/4'KW _+2FGG[GG_ !<OGX<WD1YZKLD&;B/?
MO6#LIBNF+MRS<E-SW%<-ECHK%-S]^X%"& >?OS^^ILC!T5U^JRJR_!@"/W'2
M;7\FO6C1HT:DWLYVS2N\3<;CG;? 7BK8\L.3G4U'0%EN:<HI74Y:*KDM86T8
M\&':O7Y'$T$0I%1@I-E2J2KMDW4["K"H1BXEOL?#5EK;W-25%;#0K$\T%*4$
MQCDFCA:1>\94Y8N\$DF6&(U8C)&-=8(C/*D08*7) +9QD*6WP"=\8'J1J_U+
MTK>[%!5-9'<QM^2614(JDJDTR211)1,P'343.6K@8AR& #$,40,4P (" AJG
MSV_</L"IL5W((((+T1!!V(([_H1IR^AY_P"UB_C_ ,.K@MS'7>HNP+)R6UO<
M5A/*5_S!CZ@XO5NU_P ?/:FG1;M/6#'M<G9JP5,MCE(F<"'5FWTFQ($G&LW1
M'+%RF=$ (4QJWL79-5\7T!O]FNE!1VVLK*\4M'6+4&KI88:R>&*&H,*21=X(
MDC?W'8%74YWTMEN(IG[F6-F=%3F92 K$HI)7.^,DC??;48[WOB#U!&)LE[#]
MK%*L^")H8^KY5R'D#-+F-<4P]&H]U@%D*LW3HJ]@EU;),W%W5I&.169I,!C(
M&;76=$6;MT5WZDX5_P!#UQH>+;_507:+GGM]%1VM76I]KJJ68&H8U:PQB"*F
M6H1R&+]Y-" N&)')J@W-&IH5,9V=FD(*\JL/=]W)R6*D;8P#J*N)_30;QL,9
M3QKF"M[C=O[JPXJOU/R/!-4D,BME'4O2+#'6:-;$<*5<$T#.'D8BB"J@^-/O
M[C_B Z?[CVX\-W.WUUMGLEW6&X4=312L6HV"QU4+P.W*)\GE5R<#<XVWUQ2T
MU".KB6+*,K#Z_52"/L^8U,Y[ZI[;#'/'<>^VP[AFCU@Y79O&J[['::[9TU5.
M@X;K)FL@&(JBL0Z:A#  E.42B'(:C*=@5]=5=+]9F1U#*P2M(96 *D$0X(((
M(.N_TQ%_8R?FO]^OO[B:WDWU$VS/&$]MO<L=N&+Z9GJYN+)&9S4>.Y:[S=1J
M$/$UJ9KY: VL+(8./4N]WC'?Q)TW<#*L2BDV,1(%@XV:>A[&.)J^&]*U[KZF
MTTJP26KE6.EBJ:B62>*;VPPMWKBEI)%Y%9>[?=LG&OLH>Z0(8OZ)$E;(DS[Q
M"@*R\H.PYW!SXC5.N??3>[@-NF$LK9WO6Y3 AJGB6A6:^S;9BSR!\1DFU<BW
M,@2'B@=5Q!LI+S;A%&(B4EUD45I)ZU2453*<3A9-H[;+1>KI;[326.[^T7&K
M@I(F9Z/D1II%0RR<LQ81Q*3)(0"1&C$ XTBDM<L4;R-+%A%+'ZV3@9P/=ZGH
M/72Y&KKTUZ-&C1HT:^_!UF9L?NOA#-1W[/P>X\8<^/W'F\7/^?P*\?Y1UPFJ
M(X.7O&"\^<9.,\N,_P QHP3T&?S_ +CJ0.]K&KC#V\3='C!=N9L2DY]RQ!,"
M"42 K"MKM-&@7B91 !!!_"*1[YOR "*#A,> YXTT<+5RW+AJP5ZGF]JM%OE?
M?)$II8A,I._O)*'1OQ*==JA.2>9,8Y9' ^ 8X_=C&HOZ?M<=&C1KJ.$,JSV"
M\RXIS15S&"PXHR)3<APY 4%(KA]4+!'SR+-8X /+9\+'V;M,Q3IJMEU4E2'3
M.8AD%UM\-VMEPM<_]3<**IHI#C/*M3"\)8=/>3GYE(((8 @@C.O2.8W21>J,
MKCXJ01_+?6MQ2+A Y#IE1O\ 5GA9&L7BL0%PKD@3CM?0-FBFDU$/"]IC%[7,
M>];K!VF,'!PX,(??7YVU5--1U-31U"\D]+/-33I]R:"1HI%WP?==6'0=-316
M#JK+N&4,#Z$9'[CI)KU4F'/E_<=MNSJU:^)KDW$D_CV272)_"5F\4V@9<CAT
M< X!VYALFQS-(3B JM8<I4P$&J@AJ+L!N??66]VEFRU#<8:U 3N(KA!W1"_A
M66A=CY-+^+3#>(\2Q2??0J=O&,YR3ZAP!\-2_P#2HX7^%8AW2[@WC3^+=<@U
M#$L$Z5)VG398\@%[98/:"( )F\@\R+!)N#AW)G<0A$RB"C=4-1S_ "@+GWER
ML%G5MJ6CJ;C*H.Q:MF%/#S?B1:*4J.N)23L1KM9X\)-+]YEC'IR#F/Y\X_+;
MQTV;K/.GK66'U1,0?0KJ%[O,;I-?8L&6;+9:(-F!.PC2LY'73R/5VR0<!RBW
MKULC$43?S)IE-_CK?7 5R^EN#>'*TMSNUKIZ>5\Y+3T0-%.Q]3-3N2/ DC4/
MJT[NIG7_ %C,/T7/.H^2L-:$O23PG] .G)M+H"S3V4J[Q3%9#L*!R=KI*P99
M<O,G2K5\(@!C.XQQ;/A!P,)O"2/3;$-XD4P#'/:'=/ICC7B*L#<T:W"2CA/V
M3#;U6@C9?)76G[SU+EB,DZDU%'W=+ O0E Y\\O[Y!]1S8^6J[/4P[A?I9L,A
M\-QK[P3^Y+)T%7'38BGB74H>/#HWVT.DC%'R"0ED84&*=IEX(LTFUDEC>,YD
ME9GV'6;Z0XNDN4B9ALE#-.K$9 JZP&CIU(Z;PO5R*3T:($#(R$MVEY*<1CK*
MX!_13WC_ !!!\]9_.M@ZC>C1HT:-&F..@=L58;O(O=)-6 J#6*I<AAR+B7KQ
M(QD'4A+-\G.YEJW,4A_XK%NUA%7!1XX(_;#]^[[4IVN\5OPY)8(H2QDJ4N<D
MB(1E4C:@6)F!\&9I0OJC:<K?3"H[TG&%Y,9]>?/\AKS_ *E+;DYQ'O[)F)@P
M,A5=S&/H"WI/$TA39_/-$9,J#<HQ$  ""Y3C(NF6-^<O]XXM7E/RJHH8W?L0
MO:W'A VQWS46.LFIRI.6]DJW>LII#O\ 5[R2I@0>"TX V U]NL7)4\XZ3*&]
M.90$8#Y!2?5L^.EY]7)ILT:-&C1HUI#= #<+]>NFKB6,D'WO;/@:5L.!Y_N4
MY539U%5K+T8@)&$5"-VV.;'48M(_(I*+1KD$A+XSI)8F[7[-]$<<7&1$Y8+O
M'#=X=MBU2&CJSD;%FKH:F0C8@.N>H)E-ME[RD0>,1,9^"[K\N0J/D=1Z]3;A
MOY]Z?\!D]HU[Y'!6:Z?/O7@$[S-ZG>6LICV4;B/[IINK/.4A4Q^>.YDFF(")
MP$KSV%W+V/C"6A9L)=K74PJN<9J*5HZV-O4K!#5 #\9/AKE=H^:F5\;QR*2?
M)7RI_-BFIH=$/"_T1Z8^U^(<M/;3-^JLCF2;4$GC4>'RM-R%OK[A4H@ ]Z5)
MD*LP 3<B9-DF;[<@ 1CM3NGTKQU?I%;FBHZA+9$,Y"BW1)33 'UJDJ']"Y&N
M]OC[NDB\W!D_;)9?X2NIQ8?W!U',E^W'X_KHE^)[<<LQ6*K&<'!%OB#R2Q9C
MW(GQ-),I2F;((2-RF*F=)03F&1J4DJ!NQ0A2Q6Y6:IME)9*R?^KO=NDN$&V.
M14KZRB[LGQ8I31U&1MR5$8Z@Z4QRK(TJCK$X0^N45L_Q%?BITG[UY-H;S)'5
MWVKPD*S6(TWB0V&Z9(OT$Q*<+#$W];&]E>&4*''CA**I3G[AP(\MVQ#F.!4T
M2";2'9+Q&M#V<\02RL"W#4MRJD0G;N9*,5L"#UEJQ4H%'5B/%M,=R@+UL0'_
M 'XC7.^0>;D/Y+RG/Q\LEW1@P9Q;%E&1S9%E'QS1LP8LVY 3;M&;1$C=JV03
M+^*:*""9$DB!]BD(4H?8-9:=VD=I'8N[LSNS'+,S$EF).Y))))\3J0    ;
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M1;-D57#APJF@@@@F=59=94X)I(HI)@8ZJJIS%(FF0ICG.8"E 1$ U\)"@LQ
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G'JSR.6=V/FQ)TO "@*H"@;    #R &PU]K7+7W1HT:-&C1HT:__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g582596snap111.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g582596snap111.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M!?&VA_$#PUIWB?0)_,L[V/$L#%?M%A>1@"YL+M!_J[F&0[3V8%77*.I/GX_
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M> ?_ "+>,_\ LH,5_P"D0/K*OD3]\/F3]KC_ )(W?_\ 8?T#_P!*VKZC@_\
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MWU6B/7/^&6_@M_T+%S_X/-:_^3J\?_6K._\ H*7_ (*I_P#R)^@?\0-\-?\
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M^L)'X=U.XL[;3]2L8)]4ANGOK>:ZM&A^P1REX9(()&$@&W '/(H2>W8-C@-
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= Z$1=I?"X+S.?[#3]V85 ^TGYOD&XOHEV#8__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
